The Mark Foundation for Cancer Research
Emerging Leader Award
Full application due 5 PM ET on July 30, 2026 (by invitation only); Letter of Intent was due April 30, 2026
Last verified:
Details
| Funder | The Mark Foundation for Cancer Research |
| Budget | $1,000,000 USD over 4 years ($250,000/year) |
| Deadline | 30 July 2026 |
| Duration | 4 years |
| Consortium | No |
| Application | 2-stage: Letter of Intent (due April 30, 2026) → invited full application (due July 30, 2026) → virtual finalist interviews (week of October 12, 2026) |
| Frequency | Annual |
| Career stage | Early-career opportunity |
Eligibility & scope
For early-career independent investigators (lab established 3–8 years prior to Dec 31, 2026; i.e., 2018–2023). Open worldwide to non-profit academic/research institutions. Single PI only; no co-investigators. Applicants must have multi-year independent funding active in 2027. Proposals must be in English and distinct from the applicant's main research portfolio. Indirect costs capped at 10% of direct costs.
More from The Mark Foundation for Cancer Research
Momentum Fellowships
Drug Discovery Partnership Awards
Postdoctoral Fellowships
Aspire I Award
Up to $250,000 (up to $500,000 for clinical studies)Emerging Leader Awards
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free